MMC

DRUG5 trials

Sponsors

University of Colorado, Denver, Shiyou Zhou, Sun Yat-sen University, Shahid Beheshti University of Medical Sciences, Janssen Research & Development, LLC

Conditions

GlaucomaNon-Muscle Invasive Bladder NeoplasmsPterygiumRecurrent Pterygium

Phase 1

Use of Ranibizumab With Mitomycin C During Trabeculectomy

CompletedNCT00661583

University of Colorado, DenverGlaucoma

Start: 2008-04-30End: 2014-09-30Updated: 2016-10-13

Phase 3

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method

Shahid Beheshti University of Medical SciencesGlaucoma

Start: 2014-12-31Target: 126Updated: 2015-03-11

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

RecruitingNCT06319820

Janssen Research & Development, LLCNon-Muscle Invasive Bladder Neoplasms

Start: 2024-04-18End: 2032-12-31Target: 641Updated: 2026-03-13

Unknown Phase

Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane

CompletedNCT01319721

Shiyou ZhouRecurrent Pterygium

Start: 2010-12-31End: 2014-06-30Updated: 2015-03-19

Intraoperative Mitomycin C, Amniotic Membrane Transplantation and Conjunctival Autograft for Primary Pterygium

Sun Yat-sen UniversityPterygium

Start: 2015-12-31End: 2017-12-31Target: 750Updated: 2015-12-17

Related Papers

Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle‐Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial

The Journal of Urology2025-03-064 citations

Mitomycin C-augmented trabeculectomy: subtenon injection versus soaked sponges: a randomised clinical trial

British Journal of Ophthalmology2017-01-1871 citations